A real-time biochemical assay for quantitative analyses of APOBEC-catalyzed DNA deamination

Christopher A Belica1, Michael A Carpenter2, Yanjun Chen3

  • 1Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA; Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.

Insights

Researchers developed a new assay to study APOBEC3 enzymes, which are linked to cancer. This real-time, high-sensitivity method aids in discovering inhibitors for these cancer-associated deaminases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The role of APOBEC3 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3) cytosine deaminases in cancer mutagenesis is increasingly recognized.
  • A need exists for robust biochemical tools to identify and characterize inhibitors targeting the APOBEC3 enzyme family.

Purpose of the Study:

  • To develop a novel, real-time assay for monitoring APOBEC3-mediated DNA deamination.
  • To provide a sensitive and scalable method for the discovery of APOBEC3 inhibitors.

Main Methods:

  • Development of a single-step, real-time fluorescent assay for APOBEC3 activity.
  • Utilizing the assay to gain insights into enzyme kinetics.
  • Demonstrating the assay's sensitivity and scalability for inhibitor screening.

Main Results:

  • A new real-time APOBEC3-mediated DNA Deamination assay was successfully developed.
  • The assay provides real-time fluorescent read-outs and insights into enzyme kinetics.
  • The method is highly sensitive, easily scalable, and adaptable for high-throughput screening.

Conclusions:

  • The developed assay is a valuable addition to the existing APOBEC3 research toolkit.
  • This assay facilitates the identification and characterization of potential APOBEC3 inhibitors.
  • The assay's versatility supports its adaptation for high-throughput drug discovery efforts targeting cancer mutagenesis.